Cochrane · systematic review · CD005398
Antiepileptic drugs for the primary and secondary prevention of seizures after stroke
Chang, RS, Leung, WCY, Vassallo, M, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
EpilepsyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
3
No studies
3
Included studies
NR
No studies 3 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 16.7%Moderate 2 · 33.3%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: patients with stroke
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary outcomes | no estimate extracted | NR | No studies |
Primary seizure prophylaxis after stroke | RR 0.65 [0.34, 1.26] | 2 studies · 856 participants | Moderate |
Secondary seizure prophylaxis after stroke | no estimate extracted | NR | No studies |
Secondary outcomes | no estimate extracted | NR | No studies |
Proportion of participants who had died or become dependent at the end of the scheduled | RR 0.97 [0.73, 1.27] | 2 studies · 856 participants | Moderate |
NIHSS from admission for SICH to 12 months | no estimate extracted | 1 study · 72 participants | Low |